Zhao J, Lin E, Cai C, Zhang M, Li D, Cai S, . . . Li J. (2022). Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1&alpha. Dove Medical Press.
Chicago Style (17th ed.) CitationZhao J, et al. Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1&alpha. Dove Medical Press, 2022.
MLA (9th ed.) CitationZhao J, et al. Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1&alpha. Dove Medical Press, 2022.
Warning: These citations may not always be 100% accurate.